Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non–Small-Cell Lung Cancer and Poor Performance Status When successive randomized trials ...
Mike Lee receives relevant research funding from the Australian Research Council, the Australia-Pacific Science Foundation, and Flinders University. Benedict King receives funding from the Australian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback